Marshall Wace
RXST icon

Marshall Wace’s RxSight RXST Stock Holding History

Marshall Wace’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.4K Sell
12,725
-64,607
-84% -$536K ﹤0.01% 2928
2025
Q4 		$806K Buy
+77,332
New +$776K ﹤0.01% 2038
2024
Q3 		– Sell
-324,289
Closed -$19.5M – 2898
2024
Q2 		$19.5M Buy
+324,289
New +$18.5M 0.03% 510
2022
Q1 		– Sell
-6,034
Closed -$68K – 3927
2021
Q4 		$68K Sell
6,034
-11,671
-66% -$140K ﹤0.01% 3484
2021
Q3 		$224K Buy
+17,705
New +$244K ﹤0.01% 2766

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Marshall Wace's RXST Position: Q1 2026 in Review

Marshall Wace reduced its RxSight (RXST) stake by 84% in Q1 2026, selling an estimated $536K and leaving 12,725 shares worth $78.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2928.

Marshall Wace first reported a position in RXST in Q3 2021 and has held it in 5 quarters since. The position peaked at $19.5M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Marshall Wace held 12,725 shares of RxSight worth $78.4K as of Q1 2026.
  • Marshall Wace sold 64,607 RxSight shares in Q1 2026, an estimated $536K.
  • RxSight made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2928 holding.
  • Marshall Wace first reported a position in RxSight in Q3 2021 and has held it in 5 quarters since.
  • Marshall Wace's RxSight position peaked at $19.5M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.